A novel DPP10 (intergenic)-NTRK3 fusion in a patient with facial malignant melanoma and potentially benefit from NTRK inhibitors. (September 2021) - Wei, Dongliang; Chen, Dongsheng; Li, Si; Xiao, Mingzhe; Ren, Guoxin